Article
Serotonin transporters.
Current drug targets. CNS and neurological disorders - 1 Oct 2002
Inoue Takeshi, Kusumi Ichiro, Yoshioka Mitsuhiro
Abstract excerpt
The serotonin transporter is most well known as the site of action of the serotonin reuptake inhibitors, which were initially developed as antidepressants, but now are the most widely used agents in the treatment of many additional neuropsychiatric and related disorders. The discovery that the se...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
